It does not say there is no competing contract, it says no contract would prevent fulfilment of its contract. The EU contract stipulates that the delivery schedule is only an estimate, so another contract that was estimated to permit that delivery schedule would not conflict. It also seems to stipulate that the initial 300M doses will be manufactured within the EU, but this is incidental to this claim.